Patent · US Expired

Bombesin analogs for treatment of cancer

US6989371B1 · kind B1 · utility

0Cited by
11References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2000
Grant dateJan 24, 2006
Priority date
Expiry dateAug 21, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention encompasses novel peptides that are antagonists to bombesin and bombesin like peptides and are useful in the treatment of cancer. The invention particularly relates to the design and synthesis of the novel peptides incorporating α,α-amino acids in a site specific manner. The invention encompasses methods for the generation of these peptides, compositions containing the peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.